1,2-diamino-4-nitrobenzene: reagent for determination of selenium in milk with gas chromatograph [MeSH]
4-nitro-1,2-phenylenediamine : The primary amino compound that is 1,2-phenylenediamine (o-phenylenediamine) substituted at the 4- (para-) position by a nitro group. [CHeBI]
Synonym |
AC-2759 |
(2-amino-5-nitro-phenyl)-amine |
o-phenylenediamine, 4-nitro- |
4-nitro-1,2-phenylenediamine |
4-nopd |
4-nitro-o-phenylenediamine |
99-56-9 |
nsc5378 |
nci-c03941 |
2-amino-4-nitroaniline |
c.i. 76020 |
nsc-5378 |
4-nitro-1,2-diaminobenzene |
4-nitro-1,2-benzenediamine |
p-nitro-o-phenylenediamine |
wln: zr bz dnw |
4-n-o-pda |
3,4-diaminonitrobenzene |
4-nop |
4-no |
1,2-diamino-4-nitrobenzene |
4-nitrobenzene-1,2-diamine |
nsc 5378 |
ci 76020 |
1,2-benzenediamine, 4-nitro- |
4-nitrophenylenediamine |
einecs 202-766-3 |
4-nitro-o-phenylene-diamine |
hsdb 2895 |
brn 0608106 |
ai3-52605 |
4-nitro-1,2-fenylendiamin [czech] |
4-nitro-para-phenylenediamine |
ccris 451 |
4ndb |
NCGC00091593-01 |
STK317795 |
inchi=1/c6h7n3o2/c7-5-2-1-4(9(10)11)3-6(5)8/h1-3h,7-8h |
4-nitro-o-phenylenediamine, 98% |
NCGC00091593-02 |
D0103 |
chebi:67116 , |
CHEMBL433721 |
AKOS000119818 |
BBL016368 |
NCGC00091593-03 |
C19384 |
tox21_302811 |
NCGC00256320-01 |
cas-99-56-9 |
dtxcid30958 |
dtxsid9020958 , |
NCGC00259862-01 |
tox21_202313 |
4-nitrobenzene-1,2-diamine;1,2-diamino-4-nitrobenzene |
4-13-00-00075 (beilstein handbook reference) |
4-nitro-1,2-fenylendiamin |
unii-5a9ax7y0tt |
nitro-o-phenylenediamine |
5a9ax7y0tt , |
FT-0614201 |
p-nitro-o-phenylendiamine |
SCHEMBL78293 |
4-nitrophenylene diamine |
3,4-diamino-nitrobenzene |
4-nitro 1,2-phenylenediamine |
4-nitro-ortho-phenylenediamine |
4-nitro-o-phenylene diamine |
4-nitro-benzene-1,2-diamine |
2-amino-5-nitroaniline |
4-nitro 1,2-phenylene diamine |
4-nitro-o-phenylenediamine [who-dd] |
4-nitro-o-phenylenediamine [mi] |
o-phenylenediamine, 4-nitro- [hsdb] |
1,2-diamino-4-nitrobenzene [iarc] |
4-nitro-o-phenylenediamine [inci] |
W-100032 |
mfcd00007724 |
CS-W007627 |
F0001-2335 |
GS-3013 |
1,2-benzenediamine,4-nitro- |
58833-52-6 |
Q5649571 |
CCG-325544 |
EN300-19619 |
D77683 |
4-nitrobenzene-1 |
4-nitro-1,2-diamino-benzene |
2-amino-4-nitrophenylamine |
Z104474480 |
Assay ID | Title | Year | Journal | Article |
AID1243765 | Mutagenicity in Salmonella typhimurium TA98 assessed as mutagenicity index at 10 ug/plate incubated for 90 mins at 37 degC in absence of liver S9 fractions by Ames test relative to untreated control | 2015 | European journal of medicinal chemistry, Aug-28, Volume: 101ISSN: 1768-3254 | Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines. |
AID23442 | Partition coefficient (logP) | 1991 | Journal of medicinal chemistry, Feb, Volume: 34, Issue:2 ISSN: 0022-2623 | Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity. |
AID1243789 | Mutagenicity in Salmonella typhimurium TA97a assessed as mutagenicity index at 10 ug/plate incubated for 90 mins at 37 degC in absence of liver S9 fractions by Ames test relative to untreated control | 2015 | European journal of medicinal chemistry, Aug-28, Volume: 101ISSN: 1768-3254 | Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines. |
AID1761351 | Genotoxicity in Salmonella typhimurium TA1537 assessed as number of revertant by Ames spot test relative to solvent control | 2021 | European journal of medicinal chemistry, Feb-05, Volume: 211ISSN: 1768-3254 | |
AID1243831 | Mutagenicity in Salmonella typhimurium TA100 assessed as mutagenicity index at 10 ug/plate incubated for 90 mins at 37 degC in presence of liver S9 fractions by Ames test relative to control | 2015 | European journal of medicinal chemistry, Aug-28, Volume: 101ISSN: 1768-3254 | Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines. |
AID1265553 | Mutagenicity in Salmonella typhimurium TA98 assessed as number of revertants at 10 ug/plate by Ames test (Rvb = 23 +/- 3 No_unit) | 2016 | European journal of medicinal chemistry, Jan-01, Volume: 107ISSN: 1768-3254 | Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols. |
AID1720784 | Genotoxicity in Salmonella typhimurium TA98 assessed as mutagenic index at 2.5 ug by AMES test | 2020 | Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16 ISSN: 1464-3405 | |
AID1570687 | Mutagenicity in Salmonella typhimurium TA100 at 2.5 ug/plate preincubated for 20 mins followed by addition of top agar and measured after 48 hrs by Ames test | 2019 | Bioorganic & medicinal chemistry letters, 11-01, Volume: 29, Issue:21 ISSN: 1464-3405 | Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system. |
AID1720774 | Genotoxicity in Salmonella typhimurium TA98 assessed as number of revertant at 2.5 ug by AMES test (Rvb = 8 to 8.3 No_unit) | 2020 | Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16 ISSN: 1464-3405 | |
AID732979 | Mutagenicity in Salmonella typhimurium TA98 at 20 ug/plate in absence of S9 fraction | 2013 | European journal of medicinal chemistry, Jan, Volume: 59ISSN: 1768-3254 | Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates. |
AID1243813 | Mutagenicity in Salmonella typhimurium TA98 assessed as mutagenicity index at 10 ug/plate incubated for 90 mins at 37 degC in absence of liver S9 fractions by Ames test relative to control | 2015 | European journal of medicinal chemistry, Aug-28, Volume: 101ISSN: 1768-3254 | Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines. |
AID1761352 | Genotoxicity in Salmonella typhimurium TA98 assessed as number of revertant by Ames spot test relative to solvent control | 2021 | European journal of medicinal chemistry, Feb-05, Volume: 211ISSN: 1768-3254 | |
AID200690 | Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol | 1991 | Journal of medicinal chemistry, Feb, Volume: 34, Issue:2 ISSN: 0022-2623 | Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity. |
AID1570689 | Mutagenicity in Salmonella typhimurium TA102 at 2.5 ug/plate preincubated for 20 mins followed by addition of top agar and measured after 48 hrs by Ames test | 2019 | Bioorganic & medicinal chemistry letters, 11-01, Volume: 29, Issue:21 ISSN: 1464-3405 | Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system. |
AID1570688 | Mutagenicity in Salmonella typhimurium TA98 at 2.5 ug/plate preincubated for 20 mins followed by addition of top agar and measured after 48 hrs by Ames test | 2019 | Bioorganic & medicinal chemistry letters, 11-01, Volume: 29, Issue:21 ISSN: 1464-3405 | Design, synthesis and evaluation of activity and pharmacokinetic profile of new derivatives of xanthone and piperazine in the central nervous system. |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
agmatine | | guanidines; primary amino compound | Escherichia coli metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aminoethylphosphonic acid | | phosphonic acids; primary amino compound; zwitterion | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-amino-1,2-oxazolidin-3-one | | hydroxamic acid ester; oxazolidines; primary amino compound; serine derivative | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phosphorylethanolamine | | phosphoethanolamine; primary amino compound | algal metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(3-(aminomethyl)benzyl)acetamidine | | aralkylamine; carboxamidine; primary amino compound | angiogenesis inhibitor; EC 1.14.13.39 (nitric oxide synthase) inhibitor; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | | imidazopyridine; primary amino compound | carcinogenic agent; mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-aminoethoxydiphenyl borate | | organoboron compound; primary amino compound | calcium channel blocker; IP3 receptor antagonist; potassium channel opener | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methoxytyramine | | monomethoxybenzene; phenols; phenylethylamine; primary amino compound | biomarker; human blood serum metabolite; human urinary metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxy-4-methoxyphenethylamine | | monomethoxybenzene; phenols; phenylethylamine; primary amino compound | human metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(nonyloxy)tryptamine | | aromatic ether; primary amino compound; tryptamines | serotonergic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methoxytryptamine | | aromatic ether; primary amino compound; tryptamines | 5-hydroxytryptamine 2A receptor agonist; 5-hydroxytryptamine 2B receptor agonist; 5-hydroxytryptamine 2C receptor agonist; antioxidant; cardioprotective agent; human metabolite; mouse metabolite; neuroprotective agent; radiation protective agent; serotonergic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alendronate | | 1,1-bis(phosphonic acid); primary amino compound | bone density conservation agent; EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amfenac | | amino acid; benzophenones; oxo monocarboxylic acid; primary amino compound; substituted aniline | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ampyrone | | primary amino compound; pyrazolone | antipyretic; antirheumatic drug; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; marine xenobiotic metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-aminothiazole | | 1,3-thiazoles; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amlodipine | | dihydropyridine; ethyl ester; methyl ester; monochlorobenzenes; primary amino compound | antihypertensive agent; calcium channel blocker; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
baclofen | | amino acid zwitterion; gamma-amino acid; monocarboxylic acid; monochlorobenzenes; primary amino compound | central nervous system depressant; GABA agonist; muscle relaxant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benserazide | | carbohydrazide; catechols; primary alcohol; primary amino compound | antiparkinson drug; dopaminergic agent; EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butamben | | amino acid ester; benzoate ester; primary amino compound; substituted aniline | local anaesthetic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cgs 15943 | | aromatic amine; biaryl; furans; organochlorine compound; primary amino compound; quinazolines; triazoloquinazoline | adenosine A1 receptor antagonist; adenosine A2A receptor antagonist; antineoplastic agent; central nervous system stimulant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cystamine | | organic disulfide; primary amino compound | EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fipronil | | (trifluoromethyl)benzenes; dichlorobenzene; nitrile; primary amino compound; pyrazoles; sulfoxide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tele-methylhistamine | | imidazoles; primary amino compound | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mescaline | | methoxybenzenes; phenethylamine alkaloid; primary amino compound | hallucinogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mexiletine | | aromatic ether; primary amino compound | anti-arrhythmia drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monodansylcadaverine | | aminonaphthalene; primary amino compound; sulfonamide; tertiary amino compound | EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor; fluorochrome; protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
entinostat | | benzamides; carbamate ester; primary amino compound; pyridines; substituted aniline | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
muscimol | | alkaloid; isoxazoles; primary amino compound | fungal metabolite; GABA agonist; oneirogen; psychotropic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide | | naphthalenes; organochlorine compound; primary amino compound; sulfonamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxidopamine | | benzenetriol; catecholamine; primary amino compound | drug metabolite; human metabolite; neurotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
o-methyltyramine | | primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-aminopropanol | | amino alcohol; primary alcohol; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulfaphenazole | | primary amino compound; pyrazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial drug; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor; P450 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
terazosin | | furans; piperazines; primary amino compound; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tosufloxacin | | 1,8-naphthyridine derivative; amino acid; aminopyrrolidine; monocarboxylic acid; organofluorine compound; primary amino compound; quinolone antibiotic; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tyramine | | monoamine molecular messenger; primary amino compound; tyramines | EC 3.1.1.8 (cholinesterase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tromethamine | | primary amino compound; triol | buffer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-anisidine | | monomethoxybenzene; primary amino compound; substituted aniline | genotoxin; reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aminacrine | | aminoacridines; primary amino compound | acid-base indicator; antiinfective agent; antiseptic drug; fluorescent dye; MALDI matrix material; mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-anisidine | | methoxybenzenes; primary amino compound; substituted aniline | genotoxin; reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
betazole | | primary amino compound; pyrazoles | diagnostic agent; gastrointestinal drug; histamine agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenetidine | | aromatic ether; primary amino compound; substituted aniline | drug metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-aminonicotinamide | | aminopyridine; monocarboxylic acid amide; primary amino compound | antimetabolite; EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor; teratogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kynuramine | | kynurenamines; primary amino compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
neutral red base | | aromatic amine; phenazines; primary amino compound; tertiary amino compound | acid-base indicator; dye; two-colour indicator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-tyramine | | primary amino compound; tyramines | human urinary metabolite; neurotransmitter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,6-diaminotoluene | | diamine; primary amino compound | mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrazon | | benzenes; organochlorine compound; primary amino compound; pyridazinone | environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-aminothiazoline | | 1,3-thiazoles; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-phenylpropylamine | | benzenes; phenylalkylamine; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-aminobutyric acid methyl ester | | amino acid ester; methyl ester; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
asulam | | carbamate ester; primary amino compound; substituted aniline; sulfonamide | agrochemical; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
galactosamine | | D-galactosamine; primary amino compound | toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
didesethylflurazepam | | 1,4-benzodiazepinone; monofluorobenzenes; organochlorine compound; primary amino compound | anticonvulsant; anxiolytic drug; drug metabolite; GABAA receptor agonist; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mecysteine | | L-cysteinyl ester; primary amino compound; thiol | mucolytic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,6-diaminopurine | | 2,6-diaminopurines; primary amino compound | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
st 1059 | | aromatic ether; primary amino compound; secondary alcohol | alpha-adrenergic agonist; sympathomimetic agent; vasoconstrictor agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-morpholinopropylamine | | morpholines; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oseltamivir | | acetamides; amino acid ester; cyclohexenecarboxylate ester; primary amino compound | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; environmental contaminant; prodrug; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxybenzylamine | | aralkylamino compound; aromatic ether; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-aminofluorescein | | primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylthiopropylamine | | organic sulfide; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-phenylbutylamine | | benzenes; phenylalkylamine; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
caldopentamine | | polyazaalkane; primary amino compound; secondary amino compound | marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-5-chlorophenol | | monochlorobenzenes; phenols; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aclonifen | | aromatic ether; C-nitro compound; monochlorobenzenes; primary amino compound; substituted aniline | agrochemical; carotenoid biosynthesis inhibitor; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-glutamyltyrosine | | dicarboxylic acid; dipeptide; phenols; primary amino compound; secondary carboxamide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-aminopropylphosphonic acid | | phosphonic acids; primary amino compound; zwitterion | GABAB receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-amino-1-phenylmethyl phosphonic acid | | benzenes; phosphonic acids; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fingolimod | | aminodiol; primary amino compound | antineoplastic agent; CB1 receptor antagonist; immunosuppressive agent; prodrug; sphingosine-1-phosphate receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tafenoquine | | (trifluoromethyl)benzenes; aminoquinoline; aromatic ether; primary amino compound; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dopamine 3-o-sulfate | | aryl sulfate; phenols; primary amino compound; zwitterion | human blood serum metabolite; human urinary metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dopamine 4-o-sulfate | | aryl sulfate; phenols; primary amino compound; zwitterion | human blood serum metabolite; human urinary metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chrysobactin | | catechols; dipeptide; monocarboxylic acid; primary alcohol; primary amino compound | bacterial metabolite; siderophore | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cki 7 | | isoquinolines; organochlorine compound; primary amino compound; sulfonamide | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-aminocholesterol | | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; cholestanoid; primary amino compound | antibacterial agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tyramine o-sulfate | | aryl sulfate; primary amino compound; zwitterion | human urinary metabolite; human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiobenzyl benzyloxycarbonyl-l-lysinate | | benzyl ester; carbamate ester; L-lysine derivative; primary amino compound; thiocarboxylic ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tipifarnib | | imidazoles; monochlorobenzenes; primary amino compound; quinolone | antineoplastic agent; apoptosis inducer; EC 2.5.1.58 (protein farnesyltransferase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
o 129 | | primary amino compound; pteridines | antifolate; vibriostatic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dopamine quinone | | 1,2-benzoquinones; primary amino compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(beta)-alanyldopamine | | catechols; primary amino compound; secondary carboxamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxykynuramine | | hydroxykynurenamine; primary amino compound | mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-adenosyl-3-thiopropylamine | | organic sulfide; primary amino compound; thioadenosine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aspartimide | | dicarboximide; primary amino compound; pyrrolidinone | Maillard reaction product | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monoacetylcadaverine | | acetamides; N-substituted cadaverine; primary amino compound; secondary carboxamide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-amino-8-demethylriboflavin | | aromatic amine; benzopteridine; primary amino compound; tetrol | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nsc 23766 | | aminopyrimidine; aminoquinoline; primary amino compound; secondary amino compound; tertiary amino compound | antiviral agent; apoptosis inducer; EC 3.6.5.2 (small monomeric GTPase) inhibitor; muscarinic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
paromamine | | aminoglycoside; primary amino compound; triamine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalaninol | | amino alcohol; amphetamines; primary alcohol; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(1)-guanyl-1,7-diaminoheptane | | guanidines; primary amino compound | antineoplastic agent; EC 2.5.1.46 (deoxyhypusine synthase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gs 4071 | | acetate ester; amino acid; cyclohexenecarboxylic acid; primary amino compound | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
iFSP1 | | aromatic amine; nitrile; primary amino compound; pyridobenzimidazole; toluenes | antineoplastic agent; ferroptosis inducer; ferroptosis suppressor protein 1 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
huperzine a | | organic heterotricyclic compound; primary amino compound; pyridone; sesquiterpene alkaloid | EC 3.1.1.7 (acetylcholinesterase) inhibitor; neuroprotective agent; nootropic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-acetyllysine methyl ester | | acetamides; alpha-amino acid ester; L-lysine derivative; methyl ester; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fumonisin b1 | | diester; fumonisin; primary amino compound; triol | carcinogenic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fumonisin b2 | | diester; diol; fumonisin; primary amino compound | Aspergillus metabolite; carcinogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dezocine | | phenols; primary amino compound | opioid analgesic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amrubicin | | anthracycline antibiotic; methyl ketone; primary amino compound; quinone; tetracenes | antineoplastic agent; prodrug; topoisomerase II inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitro-4-phenylenediamine | | C-nitro compound; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ro 60-0175 | | indoles; organochlorine compound; organofluorine compound; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pibutidine | | aromatic ether; cyclobutenones; olefinic compound; piperidines; primary amino compound; pyridines; secondary amino compound | anti-ulcer drug; H2-receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fortimicin a | | amino cyclitol glycoside; aminoglycoside antibiotic; diol; monocarboxylic acid amide; primary amino compound | antibacterial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
a 77636 | | adamantanes; catechols; isochromenes; primary amino compound | antiparkinson drug; dopamine agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
b 43 | | aromatic amine; aromatic ether; cyclopentanes; primary amino compound; pyrrolopyrimidine | EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nepicastat | | 1,3-dihydroimidazole-2-thiones; organofluorine compound; primary amino compound; tetralins | EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
l 779976 | | benzimidazoles; indoles; piperidinecarboxamide; primary amino compound; secondary carboxamide | neuroprotective agent; somatostatin receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fty 720p | | monoalkyl phosphate; primary alcohol; primary amino compound | antineoplastic agent; immunosuppressive agent; sphingosine-1-phosphate receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pateamine a | | 1,3-thiazoles; macrodiolide; olefinic compound; primary amino compound; tertiary amino compound | antineoplastic agent; antiviral agent; eukaryotic initiation factor 4F inhibitor; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
er-086526 | | cyclic ketal; cyclic ketone; macrocycle; polycyclic ether; polyether; primary amino compound | antineoplastic agent; microtubule-destabilising agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alogliptin | | nitrile; piperidines; primary amino compound; pyrimidines | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; hypoglycemic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(5-nitrothiazol-2-ylthio)-1,3,4-thiadiazol-2-amine | | 1,3-thiazoles; C-nitro compound; organic sulfide; primary amino compound; thiadiazoles | antibacterial agent; c-Jun N-terminal kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gsk690693 | | 1,2,5-oxadiazole; acetylenic compound; aromatic amine; aromatic ether; imidazopyridine; piperidines; primary amino compound; tertiary alcohol | antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cathestatin b | | dicarboxylic acid monoamide; epoxide; monocarboxylic acid; phenols; primary amino compound | antimicrobial agent; cysteine protease inhibitor; Penicillium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
SL-327 | | (trifluoromethyl)benzenes; enamine; nitrile; organic sulfide; primary amino compound; substituted aniline | EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lucitanib | | aromatic ether; cyclopropanes; naphthalenecarboxamide; primary amino compound; quinolines | antineoplastic agent; fibroblast growth factor receptor antagonist; vascular endothelial growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fumonisin b4 | | diester; fumonisin; primary amino compound; secondary alcohol | Aspergillus metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ML240 | | aromatic amine; aromatic ether; benzimidazoles; primary amino compound; quinazolines; secondary amino compound | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
torin 2 | | aminopyridine; organofluorine compound; primary amino compound; pyridoquinoline | antineoplastic agent; mTOR inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
crambescidin 800 | | alkaloid; carboxylic ester; guanidines; monocarboxylic acid amide; organic heteropentacyclic compound; primary amino compound; secondary alcohol; spiro compound | anti-HIV-1 agent; anti-HSV-1 agent; antimalarial; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
as 1842856 | | organofluorine compound; primary amino compound; quinolinemonocarboxylic acid; quinolone; secondary amino compound; tertiary amino compound | anti-obesity agent; antineoplastic agent; apoptosis inducer; autophagy inhibitor; forkhead box protein O1 inhibitor; hypoglycemic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pp242 | | aromatic amine; biaryl; hydroxyindoles; phenols; primary amino compound; pyrazolopyrimidine | antineoplastic agent; mTOR inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinitrochlorobenzene | | C-nitro compound; monochlorobenzenes | allergen; epitope; sensitiser | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
levoplast | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrobenzaldehyde | | benzaldehydes; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
parathion | | C-nitro compound; organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitropropionic acid | | C-nitro compound | antimycobacterial drug; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mycotoxin; neurotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid i | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azathioprine | | aryl sulfide; C-nitro compound; imidazoles; thiopurine | antimetabolite; antineoplastic agent; carcinogenic agent; DNA synthesis inhibitor; hepatotoxic agent; immunosuppressive agent; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bay-k-8644 | | (trifluoromethyl)benzenes; C-nitro compound; dihydropyridine; methyl ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benefin | | C-nitro compound; organofluorine compound; substituted aniline; tertiary amino compound | agrochemical; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dimetridazole | | C-nitro compound; imidazoles | antiparasitic agent; antiprotozoal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
etanidazole | | C-nitro compound; imidazoles; monocarboxylic acid amide | alkylating agent; antineoplastic agent; prodrug; radiosensitizing agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flunitrazepam | | 1,4-benzodiazepinone; C-nitro compound; monofluorobenzenes | anxiolytic drug; GABAA receptor agonist; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl parathion | | C-nitro compound; organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; antifungal agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; genotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metronidazole | | C-nitro compound; imidazoles; primary alcohol | antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nicardipine | | benzenes; C-nitro compound; diester; dihydropyridine; methyl ester; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
niclosamide | | benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide | anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nifedipine | | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nilutamide | | (trifluoromethyl)benzenes; C-nitro compound; imidazolidinone | androgen antagonist; antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nimesulide | | aromatic ether; C-nitro compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nimetazepam | | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; GABA modulator; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nimodipine | | 2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester | antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nisoldipine | | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; methyl ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitrazepam | | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; drug metabolite; GABA modulator; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitrendipine | | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester | antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nizatidine | | 1,3-thiazoles; C-nitro compound; carboxamidine; organic sulfide; tertiary amino compound | anti-ulcer drug; cholinergic drug; H2-receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | | aromatic ether; C-nitro compound; sulfonamide | antineoplastic agent; cyclooxygenase 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxamniquine | | aromatic primary alcohol; C-nitro compound; quinolines; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenylacetic acid | | C-nitro compound; phenylacetic acids | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ronidazole | | C-nitro compound; carbamate ester; imidazoles | antiparasitic agent; antiprotozoal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trifluralin | | (trifluoromethyl)benzenes; C-nitro compound; substituted aniline | agrochemical; environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitroquinoline-1-oxide | | C-nitro compound; quinoline N-oxide | carcinogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloramphenicol | | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
niridazole | | 1,3-thiazoles; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinitrofluorobenzene | | C-nitro compound; organofluorine compound | agrochemical; allergen; chromatographic reagent; EC 2.7.3.2 (creatine kinase) inhibitor; protein-sequencing agent; spectrophotometric reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nifenalol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloropicrin | | C-nitro compound; one-carbon compound; organochlorine compound | antifungal agrochemical; fumigant insecticide; nematicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quintozene | | aromatic fungicide; C-nitro compound; pentachlorobenzenes | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
musk ambrette (artificial) | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-chloro-2-nitrobenzene | | C-nitro compound; monochlorobenzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
picryl chloride | | C-nitro compound; monochlorobenzenes | allergen; epitope; explosive; hapten | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
picric acid | | C-nitro compound | antiseptic drug; explosive; fixative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dinitrobenzenesulfonic acid | | arenesulfonic acid; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitro-4-methylaniline | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5-dinitrobenzoic acid | | benzoic acids; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-toluidine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloronitrobenzene | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrobenzyl chloride | | benzyl chlorides; C-nitro compound | mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitroacetophenone | | acetophenones; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tecnazene | | aromatic fungicide; C-nitro compound; tetrachlorobenzene | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-amino-2-nitrotoluene | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-5-nitrothiazole | | C-nitro compound; thiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
naphthol yellow | | C-nitro compound; naphthalenesulfonic acid; naphthols | histological dye | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azomycin | | C-nitro compound; imidazoles | antitubercular agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trinitrobenzenesulfonic acid | | arenesulfonic acid; C-nitro compound | epitope; explosive; reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitrobenzaldehyde | | benzaldehydes; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-bromo-2,4-dinitrobenzene | | C-nitro compound; organobromine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5-dinitrosalicylic acid | | C-nitro compound; monohydroxybenzoic acid | hapten | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5-dinitrotoluene | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-5-nitroimidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-furaldehyde | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl acetate | | C-nitro compound; phenyl acetates | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylparaoxon | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinobuton | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrrolnitrin | | alkaloid; C-nitro compound; monochlorobenzenes; pyrroles | antifungal drug; bacterial metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinoterb | | C-nitro compound; phenols | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dinitrothiocyanatobenzene | | C-nitro compound; thiocyanates | hapten; tolerogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4,6-trichlorophenyl 4-nitrophenyl ether | | aromatic ether; C-nitro compound; chlorobenzenes | EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methylamino-2-nitro-4-n',n'-bis(2-hydroxyethyl)aminobenzene | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitroimidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(alpha-thenoylamino)-2-nitro-5-thiazole | | 1,3-thiazoles; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitroxoline | | C-nitro compound; monohydroxyquinoline | antifungal agent; antiinfective agent; antimicrobial agent; renal agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitralin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,2-epoxy-3-(p-nitrophenoxy)propane | | aromatic ether; C-nitro compound; epoxide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nimorazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-7-nitrobenzofurazan | | benzoxadiazole; C-nitro compound; organochlorine compound | EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.6.1.3 (adenosinetriphosphatase) inhibitor; fluorescent probe; fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ipronidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ornidazole | | C-nitro compound; imidazoles; organochlorine compound; secondary alcohol | antiamoebic agent; antibacterial drug; antiinfective agent; antiprotozoal drug; antitrichomonal drug; epitope | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oryzalin | | aromatic amine; C-nitro compound; sulfonamide; tertiary amino compound | agrochemical; antimitotic; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenitrothion | | C-nitro compound; organic thiophosphate | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzonidazole | | C-nitro compound; imidazoles; monocarboxylic acid amide | antiprotozoal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitro-2-furanyl)methanimine | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitro-1-propanol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amoscanate | | C-nitro compound; isothiocyanate; secondary amino compound | schistosomicide drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
profluralin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinitramine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hc blue no. 2 | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluchloralin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butralin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isopropalin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pendimethalin | | C-nitro compound; secondary amino compound; substituted aniline | agrochemical; environmental contaminant; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethafluralin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acifluorfen | | aromatic ether; benzoic acids; C-nitro compound; monocarboxylic acid; organochlorine compound; organofluorine compound | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bromethalin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fomesafen | | aromatic ether; C-nitro compound; monochlorobenzenes; N-sulfonylcarboxamide; organofluorine compound; phenols | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bmy 25067 | | C-nitro compound; organic disulfide | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
musk xylene | | C-nitro compound | carcinogenic agent; explosive; fragrance | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenylalanine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrobenzyl bromide | | benzyl bromides; C-nitro compound | allergen; sensitiser | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitarsone | | C-nitro compound; organoarsonic acid | agrochemical; antiprotozoal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5'-nitro-2'-propoxyacetanilide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cinitapride | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitrouracil | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitrobenzyl alcohol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrobenzyl alcohol | | benzyl alcohols; C-nitro compound | xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
secnidazole | | C-nitro compound; imidazoles; secondary alcohol | epitope | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl palmitate | | C-nitro compound; hexadecanoate ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl butyrate | | butyrate ester; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitrophenylacetic acid | | C-nitro compound; phenylacetic acids | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl sulfate | | aryl sulfate; C-nitro compound | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl-alpha-l-fucoside | | alpha-L-fucoside; C-nitro compound | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenylglucuronide | | beta-D-glucosiduronic acid; C-nitro compound | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloramphenicol stearate | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,5-dimethoxy-2-nitrobenzaldehyde | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl beta-d-xyloside | | C-nitro compound; xyloside | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluazinam | | (trifluoromethyl)benzenes; aminopyridine; C-nitro compound; chloropyridine; monochlorobenzenes; secondary amino compound | allergen; antifungal agrochemical; apoptosis inducer; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitropropanol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl beta-d-glucoside | | beta-D-glucoside; C-nitro compound | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl alpha-glucoside | | alpha-D-glucoside; C-nitro compound; monosaccharide derivative | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bnps-skatole | | aryl sulfide; bromoindole; C-nitro compound | reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitrophenylgalactosides | | beta-D-galactoside; C-nitro compound | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-n-(2,4-dinitrophenyl)aminohexanoic acid | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-(1-piperidinyl)pyridine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-(4-nitrobenzyl)glutathione | | C-nitro compound; organic sulfide; S-substituted glutathione | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl-2-acetamido-2-deoxy-beta-d-glucopyranoside | | C-nitro compound; N-acetyl-beta-D-glucosaminide | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
miserotoxin | | beta-D-glucoside; C-nitro compound | phytotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid ii | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitisinone | | (trifluoromethyl)benzenes; C-nitro compound; cyclohexanones; mesotrione | EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
efonidipine | | C-nitro compound; carboxylic ester; dihydropyridine; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrrolomycin a | | antibiotic antifungal agent; C-nitro compound; organochlorine compound; pyrroles | antibacterial agent; bacterial metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,8-dinitroimipramine | | C-nitro compound; dibenzoazepine; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-nitrobenzoxadiazole-6-aminohexanoic acid | | benzoxadiazole; C-nitro compound; epsilon-amino acid; secondary amino compound | fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid D | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ag 3-5 | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thymidine 5'-4-nitrophenyl phosphate | | aryl phosphate; C-nitro compound; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid c | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mesotrione | | aromatic ketone; beta-triketone; C-nitro compound; sulfone | carotenoid biosynthesis inhibitor; EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor; environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitrotyrosine | | 2-nitrophenols; C-nitro compound; nitrotyrosine; non-proteinogenic alpha-amino acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[4-(3-methyl-4-nitrophenoxy)butoxy]benzonitrile | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-nitrophenyl)-2-phenoxyacetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rubitecan | | C-nitro compound; delta-lactone; pyranoindolizinoquinoline; semisynthetic derivative; tertiary alcohol | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-nitro-5-indeno[1,2-b]pyridinone | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(4-nitrophenyl)-4-phenyl-2-thiazolamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-methyl-2-pyridinyl)-5-nitro-2-furancarboxamide | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(3,5-dimethyl-1-pyrazolyl)-(2-ethyl-4-nitro-3-pyrazolyl)methanone | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-methyl-2-pyridinyl)-5-nitro-2-furancarboxamide | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-fluoro-5-nitrophenyl)-2,2-dimethylbutanamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(2-methoxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-one | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-ethyl-6-(4-nitrophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxy-7-(4-nitrophenyl)-1,3-benzoxathiol-2-one | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3,4-dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1-ethyl-2-benzimidazolyl)-5-[(4-methyl-2-nitrophenoxy)methyl]-2-furancarboxamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[cyclohexyl(oxo)methyl]amino]-4-(3-nitrophenyl)-3-thiophenecarboxylic acid ethyl ester | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3-methoxy-5-nitrophenyl)-3-(4-methylphenyl)urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-tert-butyl-3-isoxazolyl)-3-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(2-pyridinyl)acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-methyl-5-nitrophenyl)-4,6-bis(1-pyrrolidinyl)-1,3,5-triazin-2-amine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxy-N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]benzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-2-(4-nitrophenyl)-5-thiazolecarboxylic acid | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-carbamoyl-4-methyl-2-[[(3-nitrophenyl)-oxomethyl]amino]-3-thiophenecarboxylic acid methyl ester | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(3,5-dimethyl-4-nitro-1-pyrazolyl)butanoic acid | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3-fluorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrophenyl)-4H-pyridine-3,5-dicarboxylic acid diethyl ester | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]-4-methylbenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-dimethyl-5-[[2-[2-(4-nitrophenoxy)ethoxy]phenyl]methylidene]-1,3-diazinane-2,4,6-trione | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
stattic | | 1-benzothiophenes; C-nitro compound; sulfone | antineoplastic agent; radiosensitizing agent; STAT3 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-fluoro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-4-(4,5-dimethoxy-2-nitrophenyl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbonitrile | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dichloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N2-tert-butyl-6-ethoxy-N4-(4-nitrophenyl)-1,3,5-triazine-2,4-diamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-methyl-5-[2-(3-nitroanilino)-4-thiazolyl]-2-thiazolyl]acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-N-[5-(4-nitrophenyl)sulfonyl-2-thiazolyl]pentanamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(2-ethyl-1-piperidinyl)-sulfanylidenemethyl]-4-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[3-methoxy-4-[(4-nitrophenyl)methoxy]phenyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-chloro-3-nitrophenyl)-3-phenylbutanamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene | | C-nitro compound; sulfonamide; toluenes | bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-chlorophenyl)sulfonyl-methylamino]-N-(4-methoxy-2-nitrophenyl)acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(2-nitrophenyl)-N-(2-thiazolyl)-2-furancarboxamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ranitidine | | C-nitro compound; furans; organic sulfide; tertiary amino compound | anti-ulcer drug; drug allergen; environmental contaminant; H2-receptor antagonist; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carnidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-methyl-5-nitro-N-(phenylmethyl)-2-furancarboxamide | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitro-N'-(2,4,6-trichlorophenyl)benzohydrazide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2,2-dimethyl-4-oxanyl)-4-(4-nitrophenyl)thiazole | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methyl-N-(3-methylphenyl)-4-nitro-1H-pyrazol-3-amine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitro-N-[(1-oxopentylhydrazo)-sulfanylidenemethyl]benzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[[[2-(2-methylphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-fluorophenyl)-5-nitro-2-pyridinamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide | | C-nitro compound; thiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-(1-phenylethylamino)ethyl] ester | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(5-amino-1H-1,2,4-triazol-3-yl)thio]-N-(2-bromo-4-nitrophenyl)acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenylhydrazine | | C-nitro compound; phenylhydrazines | mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(1-azepanyl)-6-hydrazinyl-N-(4-nitrophenyl)-1,3,5-triazin-2-amine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-7-methyl-4-(5-nitro-2-furanyl)-5-oxo-4H-pyrano[3,2-c]pyran-3-carbonitrile | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N4-(1,1-dioxo-3-thiolanyl)-5-nitropyrimidine-4,6-diamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N4-(3-chlorophenyl)-N2-methyl-5-nitropyrimidine-2,4,6-triamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrocatechol | | C-nitro compound; catechols | human xenobiotic metabolite; lipoxygenase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(1-naphthalenyl)-3-[[2-(2-nitrophenoxy)-1-oxoethyl]amino]urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nefurthiazole | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-(2,3-dihydro-1,4-dioxin-5-yl)-1,3,4-oxadiazol-2-yl]-5-nitro-2-thiophenecarboxamide | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-aminophenyl)thio]-N-(3-nitrophenyl)acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[4-(2-hydroxyethylamino)-3-nitrophenyl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[6-amino-2-(3-methylanilino)-5-nitro-4-pyrimidinyl]amino]ethanol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N4-(3-fluorophenyl)-N2-[3-(4-morpholinyl)propyl]-5-nitropyrimidine-2,4,6-triamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitro-N-(2-phenylethyl)-2-pyridinamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-nitrophenyl)-4-thiazolecarboxylic acid ethyl ester | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dinitrophenylhydrazine | | C-nitro compound; phenylhydrazines | reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methyl-N-[[[(4-nitrophenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]butanamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methyl-2-[[(4-nitrophenyl)-oxomethyl]hydrazo]-4-thiazolecarboxylic acid ethyl ester | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-chlorophenyl)-4-[[(2-methoxy-4-nitroanilino)-sulfanylidenemethyl]hydrazo]-4-oxobutanamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-thiophenecarboxylic acid [1-[(3,5-dichloro-2-pyridinyl)amino]-1-oxopropan-2-yl] ester | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]ethyl]-4-nitroaniline | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrocaramiphen | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(3-methyl-5-nitro-4-imidazolyl)amino]phenol | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-methoxy-4-nitrophenyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N2-(3-methylphenyl)-6-(4-morpholinyl)-5-nitropyrimidine-2,4-diamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sb 415286 | | C-nitro compound; maleimides; monochlorobenzenes; phenols; secondary amino compound; substituted aniline | antioxidant; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide | | C-nitro compound; secondary carboxamide; tertiary carboxamide; trifluoroacetamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[6-amino-2-[3-(dimethylamino)propylamino]-5-nitro-4-pyrimidinyl]amino]ethanol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(3-chlorophenyl)sulfonyl-N-cyclohexyl-N-methyl-3-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-(2-methyl-1-piperidinyl)-5-nitro-4-pyrimidinamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(5-nitro-2-thiophenyl)piperidine | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(2,4,6-trinitrophenyl)ethyl]aniline | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N2-(2-furanylmethyl)-5-nitro-6-(1-pyrrolidinyl)pyrimidine-2,4-diamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2,5-dimethyl-1-prop-2-enyl-3-pyrrolyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]ethanone | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-bromo-4-nitrophenyl)-2-[(5-propan-2-yl-1H-1,2,4-triazol-3-yl)thio]acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2,3-dihydroxypropylamino)-5-nitro-3-pyridinecarbonitrile | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-nitrophenyl)thio]-1-cyclooctanone | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[[oxo-[(phenylmethyl)amino]methyl]amino]ethyl] ester | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N2-(2-furanylmethyl)-6-(3-methyl-1-piperidinyl)-5-nitropyrimidine-2,4-diamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-(4-nitrophenyl)-9-oxo-3-bicyclo[3.3.1]nonanecarbohydrazide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alsterpaullone | | C-nitro compound; caprolactams; organic heterotetracyclic compound | anti-HIV-1 agent; antineoplastic agent; apoptosis inducer; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-fluoro-3-nitrophenyl)-4,4-dimethyl-5H-oxazole | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-[2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]acetyl]-4-nitrobenzohydrazide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
furylfuramide | | acrylamides; C-nitro compound; nitrofuran antibiotic; primary carboxamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cilnidipine | | 2-methoxyethyl ester; C-nitro compound; dihydropyridine | antihypertensive agent; calcium channel blocker; cardiovascular drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ro 61-8048 | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
meptyldinocap | | C-nitro compound; enoate ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
l796778 | | benzenes; C-nitro compound; L-lysine derivative; L-phenylalanine derivative; methyl ester; oligopeptide; secondary carboxamide; ureas | somatostatin receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amocarzine | | C-nitro compound; N-methylpiperazine; secondary amino compound; thioureas | antinematodal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitrovin | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroxymethylfuratrizine | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nifurpirinol | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azanidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aureothin | | 4-pyranones; C-nitro compound; ketene acetal; olefinic compound; oxolanes | antibacterial agent; antifungal agent; antineoplastic agent; antiparasitic agent; bacterial metabolite; EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nidroxyzone | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nifurzide | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
abt-737 | | aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-(2-chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-nitrophenyl)acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate | | C-nitro compound; spiroketal | antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-morpholinyl)-N'-[(2-nitrophenyl)-oxomethyl]-4-thiazolecarbohydrazide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-[(2-methyl-3-nitrophenyl)-oxomethyl]-2-(4-morpholinyl)-4-thiazolecarbohydrazide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ML-210 | | C-nitro compound; diarylmethane; isoxazoles; monochlorobenzenes; N-acylpiperazine; N-alkylpiperazine; tertiary carboxamide | antineoplastic agent; EC 1.11.1.9 (glutathione peroxidase) inhibitor; ferroptosis inducer; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
abt-199 | | aromatic ether; C-nitro compound; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; N-sulfonylcarboxamide; oxanes; pyrrolopyridine | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chir 98014 | | aminopyrimidine; C-nitro compound; diaminopyridine; dichlorobenzene; imidazoles; secondary amino compound | antineoplastic agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; hypoglycemic agent; tau aggregation inhibitor; Wnt signalling activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acenocoumarol | | C-nitro compound; hydroxycoumarin; methyl ketone | anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-nitroguanosine 3',5'-cyclic monophosphate | | 3',5'-cyclic purine nucleotide; C-nitro compound | biomarker; Brassica napus metabolite; human metabolite; signalling molecule | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |